Related Experiment Video
Updated: May 28, 2026

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
Published on: September 19, 2011
Fibrin as a scaffold for cardiac tissue engineering
Maria Chiara Barsotti1, Francesca Felice, Alberto Balbarini
1Cardiovascular Research Laboratory, Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy. mariachiarab@yahoo.com
Fibrin, a natural biopolymer, shows promise in cardiac tissue engineering. Its properties enhance cell delivery and retention, improving cardiac cell therapy efficacy for conditions like heart valve repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Biotechnology
Background:
- Fibrin is a natural biopolymer with advantageous properties including biocompatibility, bioresorbability, and ease of processing.
- Its nanometric fibrous structure mimics the natural extracellular matrix, supporting cell integration and autologous applications.
- A key challenge in cardiac cell therapy is poor cell engraftment, necessitating improved methods for cell retention and homing.
Purpose of the Study:
- To review the applications of fibrin in cardiac bioengineering.
- To highlight fibrin's role as both a cell delivery vehicle and an implantable biomaterial for cardiac applications.
Main Methods:
- Literature review of studies utilizing fibrin in cardiac tissue engineering.
- Analysis of fibrin's properties relevant to cardiac cell therapy and biomaterial development.
Main Results:
- Fibrin's properties make it suitable for injectable cardiac tissue engineering, potentially enhancing cell therapy efficacy.
- Fibrin-based scaffolds can improve cell retention and homing in cardiac applications.
- Fibrin can be utilized for engineering cardiac patches and heart valves.
Conclusions:
- Fibrin is a versatile biomaterial for cardiac bioengineering applications.
- Fibrin-based strategies show potential to overcome limitations in cardiac cell therapy.
- Further development of fibrin-based biomaterials can advance regenerative medicine for cardiac repair.
More Related Videos
06:173D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells
Published on: March 28, 2025
12:13Engineering Fibrin-based Tissue Constructs from Myofibroblasts and Application of Constraints and Strain to Induce Cell and Collagen Reorganization
Published on: October 28, 2013